Skip to main content

MYLAN 2264 MYLAN 2264 (Terazosin Hydrochloride 2 mg)

Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2264 MYLAN 2264

Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Front
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264 Back
Terazosin hydrochloride 2 mg MYLAN 2264 MYLAN 2264

Terazosin Hydrochloride

Imprint
MYLAN 2264 MYLAN 2264
Strength
2 mg
Color
Black / Purple
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, ammonia, propylene glycol, shellac, dimethicone

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2264 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0937 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.